BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 11150912)

  • 1. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications.
    Toi M; Gion M; Biganzoli E; Dittadi R; Boracchi P; Miceli R; Meli S; Mori K; Tominaga T; Gasparini G
    Angiogenesis; 1997; 1(1):71-83. PubMed ID: 14517395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma.
    Linderholm B; Lindh B; Tavelin B; Grankvist K; Henriksson R
    Int J Cancer; 2000 Jan; 89(1):51-62. PubMed ID: 10719731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
    Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
    Salvesen HB; Akslen LA
    Int J Cancer; 1999 Oct; 84(5):538-43. PubMed ID: 10502735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
    Linderholm B; Grankvist K; Wilking N; Johansson M; Tavelin B; Henriksson R
    J Clin Oncol; 2000 Apr; 18(7):1423-31. PubMed ID: 10735889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
    van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
    Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of angiogenic factors in breast cancer.
    Locopo N; Fanelli M; Gasparini G
    Breast Cancer Res Treat; 1998; 52(1-3):159-73. PubMed ID: 10066080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma.
    Toi M; Gion M; Saji H; Asano M; Dittadi R; Gilberti S; Locopo N; Gasparini G
    Int J Oncol; 1999 Dec; 15(6):1169-75. PubMed ID: 10568824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the angiogenic factor thymidine phosphorylase in human astrocytic tumors.
    Takano S; Tsuboi K; Matsumura A; Tomono Y; Mitsui Y; Nose T
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):145-52. PubMed ID: 10741908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
    Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
    Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Damala K; Tsanou E; Briasoulis E; Papadiotis E; Mitselou A; Charhanti A; Doukas M; Lampri L; Arvanitis DL
    Histol Histopathol; 2012 Feb; 27(2):209-16. PubMed ID: 22207555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
    Linderholm B; Tavelin B; Grankvist K; Henriksson R
    Br J Cancer; 1999 Oct; 81(4):727-32. PubMed ID: 10574263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
    Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
    Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-associated biomarker profiles of human breast cancer.
    Eppenberger-Castori S; Moore DH; Thor AD; Edgerton SM; Kueng W; Eppenberger U; Benz CC
    Int J Biochem Cell Biol; 2002 Nov; 34(11):1318-30. PubMed ID: 12200028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.